ArticleDiscover oncology2024

Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types.

Peiyi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.